Complete Remission of a Diffuse Large B-Cell Lymphoma in a Young Patient, with Severe Tuberous Sclerosis, Treated with Metronomic Chemotherapy and Ibrutinib: A Case Report

Metronomic Chemotherapy in Pediatric Oncology: From Preclinical Evidence to Clinical Studies

(2022) Marta Banchi et al.   Journal of Clinical Medicine

Remarkable Remission Rate and Long-Term Efficacy of Upfront Metronomic Chemotherapy in Elderly and Frail Patients, with Diffuse Large B-Cell Lymphoma

(2022) Guido Bocci et al.   Journal of Clinical Medicine

Metronomic chemotherapy regimens and targeted therapies in non-Hodgkin lymphoma: The best of two worlds

(2021) Maria Christina Cox et al.   CANCER LETTERS

All-oral metronomic DEVEC schedule in elderly patients with peripheral T cell lymphoma

(2020) Maria Christina Cox et al.   CANCER CHEMOTHERAPY AND PHARMACOLOGY

Randomized Phase III Trial of Ibrutinib and Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone in Non–Germinal Center B-Cell Diffuse Large B-Cell Lymphoma

(2019) Anas Younes et al.   JOURNAL OF CLINICAL ONCOLOGY

MYD88 mutations identify a molecular subgroup of diffuse large B-cell lymphoma with an unfavourable prognosis

(2019) Joost S. Vermaat et al.   HAEMATOLOGICA

The metronomic all-oral DEVEC is an effective schedule in elderly patients with diffuse large b-cell lymphoma

(2019) M. Christina Cox et al.   INVESTIGATIONAL NEW DRUGS

MYD88 in the driver’s seat of B-cell lymphomagenesis: from molecular mechanisms to clinical implications

(2019) Ruben A.L. de Groen et al.   HAEMATOLOGICA

Does metronomic chemotherapy induce tumor angiogenic dormancy? A review of available preclinical and clinical data

(2018) Gianfranco Natale et al.   CANCER LETTERS

Tuberous sclerosis complex is required for tumor maintenance in MYC‐driven Burkitt's lymphoma

(2018) Götz Hartleben et al.   EMBO JOURNAL

Ibrutinib inhibits pre-BCR+B-cell acute lymphoblastic leukemia progression by targeting BTK and BLK

(2016) Ekaterina Kim et al.   BLOOD

Adolescent and young adult non-Hodgkin lymphoma

(2016) Jessica Hochberg et al.   BRITISH JOURNAL OF HAEMATOLOGY

Pharmacokinetics of metronomic chemotherapy: a neglected but crucial aspect

(2016) Guido Bocci et al.   Nature Reviews Clinical Oncology

Clinical response to everolimus in a patient with Hodgkin’s lymphoma harboring a TSC2 mutation

(2016) G F Perini et al.   Blood Cancer Journal

MYC in DLBCL: partners matter

(2015) E. Campo   BLOOD

Targeting B cell receptor signaling with ibrutinib in diffuse large B cell lymphoma

(2015) Wyndham H Wilson et al.   NATURE MEDICINE

Excellent outcome of young adults with aggressive non-Hodgkin lymphomas treated with CHOP-like regimens

(2014) K Hohloch et al.   LEUKEMIA

Tuberous sclerosis

(2008) Paolo Curatolo et al.   LANCET